Copyright
©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Apr 28, 2006; 12(16): 2530-2535
Published online Apr 28, 2006. doi: 10.3748/wjg.v12.i16.2530
Published online Apr 28, 2006. doi: 10.3748/wjg.v12.i16.2530
Figure 3 Neutralization of HCV infection into HepG2 cells by anti E1 antibody.
The pretreated sera with anti E1 Ab or with PBS were incubated with HepG2 cells for 90 min at 37 oC in CO2 incubator. Cell pellets were washed with PBS, incubated with FITC labeled F(ab)2 portion of anti E1 Ab and analyzed with flow cytometry as described in Materials and Methods The mean fluorescence intensities decreased from 12.5% in cells incubated with PBS to 2% after treatment with anti E1 Ab using cell Quest software (Becton Dickinson).
- Citation: EL-Awady MK, Tabll AA, Atef K, Yousef SS, Omran MH, El-Abd Y, Bader-Eldin NG, Salem AM, Zohny SF, El-Garf WT. Antibody to E1 peptide of hepatitis C virus genotype 4 inhibits virus binding and entry to HepG2 cells in vitro. World J Gastroenterol 2006; 12(16): 2530-2535
- URL: https://www.wjgnet.com/1007-9327/full/v12/i16/2530.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i16.2530